Bevacizumab in 1 line of complex treatment in patients with ovarian cancer (phase III clinicaL trial)


Log in Registration Search for: Home Electronic publication Fresh number Archives Authors About Edition Subscription Requirements for authors Reviewing Editorial board
Organization of anticancer fight Tumors of the chest cavity Tumors of abdominal organs Tumors of skin, soft tissues, bones Breast tumor Oncogynecology Tumors of the head and neck Oncurology Oncohematology Radiation diagnostics, radiation therapy Experimental studies Magazine online All news	Full article in pdf format Keywords: bevacizumab (Avastin)., diagnostics, lung metastases, triple negative breast cancer Review: Share: All electronic publications №5 (1) 2012 : Chemotherapy of solid tumors Bevacizumab in 1 line of complex treatment in patients with ovarian cancer (phase III clinicaL trial) Summary. The results of clinical trials, which validate the efficacy and safety of administration of bevacizumab (Avastin) in first-line treatment of patients with ovarian cancer are presented. Follow us on social media: Статьи по теме: Clinical features of borderline ovarian tumors and estimation of results of patients’ treatment The place of neoadjuvant chemotherapy in a complex treatment of patients with breast cancer Modern approaches to the first line treatment and modern world trends of Diffuse Large B-cell lymphoma No Comments » Add your Leave a comment Name (required) Mail (will not be published) (required) Website CAPTCHA Code
MORION Publishing House Editorial office and publisher: 02140, Kyiv, ave. Bazhana 10A Tel.: 380 (44) 585-97-10 Specialized medical online publication for doctors, pharmacists, pharmacists, medical students and pharmaceutical universities.Disclaimer morion.ua apteka.ua pharmstandart.com.ua compendium.com.ua proximaresearch.com